Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
1994 • 6,495 citations
Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia
1985 • 2,981 citations
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).
1995 • 1,374 citations
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
1990 • 926 citations
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
1994 • 788 citations
Transcription Factors, Normal Myeloid Development, and Leukemia
1997 • 729 citations
Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.
1993 • 516 citations
Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores.
1990 • 226 citations
Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia.
1990 • 174 citations
Rescue from programmed cell death in leukemic and normal myeloid cells
1991 • 165 citations
Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry.
1990 • 139 citations
AML1A and AML1B can transactivate the human IL-3 promoter.
1997 • 130 citations
Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells
1993 • 107 citations
Leukemic B-cell precursors express functional receptors for human interleukin-3
1989 • 82 citations
Cellular Responses to Interferons and Other Cytokines: The JAK–STAT Paradigm
1998 • 81 citations
Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors
1992 • 78 citations
Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.
1995 • 74 citations
Impact of immunophenotyping on management of acute leukemias.
1999 • 71 citations
Autocrine growth factors and leukaemic haemopoiesis
1992 • 60 citations
Enhancement of the biologic effects of interleukin-3 in vivo by anti- interleukin-3 antibodies
1993 • 44 citations
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells
1997 • 41 citations
Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions
2000 • 38 citations
Human recombinant IL-3 is a growth factor for normal B cells.
1992 • 34 citations
Characterization of proteins binding the 3′ regulatory region of the IL-3 gene in IL-3-dependent and autocrine-transformed hematopoietic cells
1998 • 23 citations
Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivo.
1988 • 20 citations
Up‐regulation of IL‐6‐receptors by IL‐3 on a plasma cell leukaemia cell line which proliferates dependently on both IL‐3 and IL‐6
1993 • 14 citations
Abnormal expression of interleukin-3 and leukaemia.
1987 • 6 citations